Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
AC

ACAD

Market Closed

ACADIA Pharmaceuticals Inc.

NASDAQHealthcareBiotechnology
US
798 employees
CEO: Catherine E. Owen Adams
Founded: 2004
$24.84
+$0.00(+NaN%)
Market Cap
4.25B
Beta
0.80
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Overall Sentiment
80%
Very Positive
Based on 1 of 3 sources
News
80%
Social
--
Analyst
--
News Media
Overall Score80%
Positive Articles4
Neutral Articles1
Negative Articles0
Total Coverage5 articles
Social Media
No social media data available
Wall Street Analysts
No analyst recommendation data available
Social Sentiment & Market Signals
Real-time social media buzz and conversation analysis

No social sentiment data available

Social media conversation data will appear here once loaded

News Sentiment Risk Analysis
Market sentiment and news coverage impact assessment
Total Articles
5
Avg Sentiment
0.543

Positive

Positive News
80.0%
Negative News
0.0%

Sentiment Distribution & Risk Assessment

Coverage:Low
Trend:Positive
Positive
80.0%
Neutral
20.0%
Negative
0.0%
POSITIVEBased on 5 articles

Recent Headlines Impact

No recent news headlines available
Analyst Recommendations
Wall Street analyst consensus and rating distribution

No Analyst Data Available

Analyst recommendations are not available for this stock

Explore ACAD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ACAD in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms